메뉴 건너뛰기




Volumn 65, Issue 12, 2011, Pages 1240-1249

A randomised comparison of safety and efficacy of nevirapine vs. atazanavir/ritonavir combined with tenofovir/emtricitabine in treatment-naïve patients

Author keywords

[No Author keywords available]

Indexed keywords

ATAZANAVIR PLUS RITONAVIR; CHOLESTEROL; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEVIRAPINE; TRIACYLGLYCEROL;

EID: 81755166261     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02807.x     Document Type: Article
Times cited : (21)

References (10)
  • 2
    • 79959435688 scopus 로고    scopus 로고
    • Nevirapine versus atazanavir/ritonavir, each combined with tenofovir/emtricitabine, in antiretroviral-naïve HIV-1 patients: Week 48 ARTEN results
    • Soriano V, Arastéh K, Migrone H, et al., Nevirapine versus atazanavir/ritonavir, each combined with tenofovir/emtricitabine, in antiretroviral-naïve HIV-1 patients: week 48 ARTEN results. Antivir Ther 2011; 16: 339-48.
    • (2011) Antivir Ther , vol.16 , pp. 339-348
    • Soriano, V.1    Arastéh, K.2    Migrone, H.3
  • 3
    • 81755184517 scopus 로고    scopus 로고
    • Prospective comparison of nevirapine and atazanavir/ritonavir both combined with tenofovir DF/emtricitabine in treatment-naïve HIV-1 infected patients: ARTEN study week 48 results
    • 19-22 July Cape Town, South Africa
    • Soriano V, Köppe S, Mingrone H, et al., Prospective comparison of nevirapine and atazanavir/ritonavir both combined with tenofovir DF/emtricitabine in treatment-naïve HIV-1 infected patients: ARTEN study week 48 results. Paper presented at: 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 19-22 July 2009; Cape Town, South Africa.
    • (2009) 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention
    • Soriano, V.1    Köppe, S.2    Mingrone, H.3
  • 4
    • 0000642942 scopus 로고
    • Some methods for strengthening the common chi square tests
    • Cochran W,. Some methods for strengthening the common chi square tests. Biometrics 1954; 10: 417-51.
    • (1954) Biometrics , vol.10 , pp. 417-451
    • Cochran, W.1
  • 5
    • 0037629215 scopus 로고    scopus 로고
    • Sample size for K 2 2 tables in equivalence studies using Cochran's statistic
    • DOI 10.1016/S0197-2456(03)00026-6
    • Song J, Wassel J,. Sample size for K 2x2 tables in equivalence studies using Cochran's statistic. Control Clin Trials 2003; 24: 378-89. (Pubitemid 36831043)
    • (2003) Controlled Clinical Trials , vol.24 , Issue.4 , pp. 378-389
    • Song, J.X.1    Wassell, J.T.2
  • 6
    • 42549170232 scopus 로고    scopus 로고
    • Risk of early virological failure of once-daily tenofovir-emtricitabine plus twice-daily nevirapine in antiretroviral therapy-naive HIV-infected patients
    • DOI 10.1086/529394
    • Lapadula G, Costarelli S, Quiros-Roldan E, et al., Risk of early virological failure of once-daily tenofovir-emtricitabine plus twice-daily nevirapine in antiretroviral therapy-naïve HIV-infected patients. Clin Infect Dis 2008; 46: 1127-9. (Pubitemid 351589888)
    • (2008) Clinical Infectious Diseases , vol.46 , Issue.7 , pp. 1127-1129
    • Lapadula, G.1    Costarelli, S.2    Quiros-Roldan, E.3    Calabresi, A.4    Izzo, I.5    Carosi, G.6    Torti, C.7
  • 7
    • 58849099139 scopus 로고    scopus 로고
    • High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naïve HIV-1-infected patients
    • Rey D, Hoen B, Chavanet P, et al., High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naïve HIV-1-infected patients. J Antimicrob Chemother 2009; 63: 380-8.
    • (2009) J Antimicrob Chemother , vol.63 , pp. 380-388
    • Rey, D.1    Hoen, B.2    Chavanet, P.3
  • 8
    • 52149090049 scopus 로고    scopus 로고
    • Efficacy of a once daily (QD) regimen of nevirapine (NVP), lamivudine (3TC) and tenofovir (TDF) in treatment-naïve HIV infected patients: A pilot study
    • 14-17 November Glasgow, Scotland
    • Towner W, Kerrigan H, LaRiviere M, et al., Efficacy of a once daily (QD) regimen of nevirapine (NVP), lamivudine (3TC) and tenofovir (TDF) in treatment-naïve HIV infected patients: A pilot study. Paper presented at: 7th International Congress on Drug Therapy in HIV Infection, 14-17 November 2004, Glasgow, Scotland.
    • (2004) 7th International Congress on Drug Therapy in HIV Infection
    • Towner, W.1    Kerrigan, H.2    Lariviere, M.3
  • 9
    • 49649112490 scopus 로고    scopus 로고
    • Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naïve HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study
    • Molina JM, Andrade-Villanueva J, Echevarria, et al., Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naïve HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study. Lancet 2008; 372: 646-55.
    • (2008) Lancet , vol.372 , pp. 646-655
    • Molina, J.M.1    Andrade-Villanueva, J.2    Echevarria3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.